Acne Vulgaris Superficial Mixed Comedonal and Inflammatory Clinical Trial
Official title:
Evaluation of Efficacy of Topical Flutamide in the Treatment of Acne Vulgaris
From the obtained results, topical Flutamide 1% gel can be a promising, effective, and safe alternative in treating patients with acne vulgaris with minimal side effects.
Flutamide is a non-steroidal anti-androgen, which is used to treat patients with prostate cancer. Due to its anti-androgenic properties can be used in cases of acne, hirsutism, and androgenic alopecia with successful outcomes. To minimize the unnecessary systemic side effects associated with the oral administration of Flutamide. It has been shown that the topical delivery of Flutamide can allow high drug levels at the site of action, decreasing the systemic side effects and improving patient compliance. The Flutamide group received topical Flutamide 1% gel twice daily on the face for 8 weeks and the control group received the same gel components, without flutamide, twice daily on the face for 8 weeks ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03076320 -
Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT04730414 -
Full Spectrum Hemp Observational Study
|